Answers are grounded in this paper and cite their sources.
Evaluates opiranserin's antinociceptive effects in dogs, suggesting potential benefits over traditional analgesics.
Objective To evaluate the antinociceptive efficacy and safety of the novel analgesic opiranserin (a dual glycine transporter-2 inhibitor and 5-hydroxytryptamine 2A antagonist) in dogs using mechanical nociceptive threshold (MNT) testing, with low-dose remifentanil (positive control) and normal saline (negative control). Study design Randomized, blinded, crossover study. Animals Six healthy male Beagle dogs [aged 3.4–5.3 years, 13.1 ± 0.5 kg (mean ± standard deviation)]. Methods Each dog was given a 4 hour intravenous constant rate infusion (CRI) of opiranserin (5 mg kg -1 hour -1 ), remifentanil (4 μg kg -1 hour -1 ), or normal saline with ≥ 7 days inter-treatment interval. MNT (left metacarpal, carpal and metatarsal pad), pulse rate, and sedation scores were recorded at 0 (baseline), 30, 60, 120, 180, and 240 minutes. MNT and pulse rate were analyzed using linear mixed effects models. Sedation scores were analyzed using Friedman’s test. Results With opiranserin, MNT increased from 30–240 minutes versus baseline ( p < 0.001), and the opiranserin-saline difference increased over time ( p < 0.001). With remifentanil, MNT increased versus baseline from 30 minutes ( p < 0.001) without additional time-dependent increase. In a secondary comparison, MNT was higher with opiranserin than remifentanil from 60–240 minutes (all p values ≤ 0.036). Pulse rate decreased with remifentanil ( p < 0.001), but not opiranserin or saline. Sedation was 0/12 with opiranserin and saline, and increased minimally with remifentanil (1/12). Vomiting (2/6 dogs) and nausea-like signs (5/6 dogs) were the main adverse events with opiranserin. All adverse effects resolved within 30 minutes of stopping the CRI. No psychomimetic or neurological signs were observed. Conclusions and clinical relevance A 4 hour CRI of opiranserin (5 mg kg -1 hour -1 ) increased mechanical nociceptive thresholds during infusion in dogs without clinically relevant sedation or cardiovascular depression. These findings are consistent with antinociceptive activity under this experimental model.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: